Achieving consistency in IO services across the country: streamlined guidance and support
With a key focus on service development, this in-person conference was designed for all healthcare professionals working Immuno-Oncology or Acute Oncology. Those in attendance were looking to take action and plan for the future of their service. By booking their places they were able to attend and be inspired by leading clinicians with a wide range of knowledge and experience, plus network with like-minded colleagues with mutual goals. The outcome was inspired learning which will improve the care delivered to patients on immunotherapy.
With a special thanks to the IOCN for supporting this forum:
And thanks to the sponsors:
First-hand experience and perceptive learnings
Attendees were guided through the practicalities and realities of establishing an IO service, that not only fits within the hospital but also serves the patients. Key focusses included:
- National approaches to improving the management of IO toxicities
- Providing effective and on-going training across your hospitals for recognising and signposting IO patients
- Creating a dedicated IO toxicity clinic: overcoming the barriers
- Enhancing your assessment skills and clinical practice
- Establishing IO urgent pathways: A&E
hotlines and ambulatory care
This dedicated training day armed the participants with the tools to deliver an effective service:
- Building networks: access to Immuno-Oncology professionals and thought leaders to build a community of peers for support, advice and guidance
- Professional learning: developed understanding; examining and overcoming key issues that underpin evolving IO services
- Service development: identifying innovative approaches for enhancing pathways and improving patient experience
With thanks to our industry sponsors
With thanks to our partner
This conference has been created in collaboration with and through support from IOCN.
| 9:00 |
Registration and networking
|
| 9:30 |
Chair’s opening remarks and introductions
Dr Anna Olsson-Brown, Consultant in Medical Oncology and Clinical Director for Clinical Cancer Care, University Hospitals Sussex NHS Foundation Trust
|
| IO National Picture | |
| 9:40 |
Keynote presentation: Developing IO services to improve the management of toxicities
Trudy Guinan, Immuno-Oncology Nurse Consultant, Clatterbridge Cancer Centre NHS Foundation Trust
|
| Upskilling the MDT | |
| 10:05 |
Providing effective and resourceful education across your hospital: recognising and signposting IO patients
Emily Keen, Macmillan Lead Nurse for Immunotherapy, Royal Free London NHS Foundation Trust
|
| 10:30 |
Questions and answers with your speakers
|
| 10:40 |
Interactive discussion: Implementing effective, on-going IO education in your hospital
|
| 10:55 |
Feedback from interactive discussion: Implementing effective, on-going IO education in your hospital
|
| 11:05 |
An Introduction to Regeneron in the UK
James Winterman, Country Manager – UK/IE (Oncology), Regeneron
|
| 11:20 |
Networking break and opportunity to meet the sponsors
|
| Creating a toxicity clinic | |
| 11:40 |
Building and developing a dedicated IO toxicity clinic
Dr Anna Olsson-Brown, Consultant in Medical Oncology and Clinical Director for Clinical Cancer Care, University Hospitals Sussex NHS Foundation Trust
|
| 12:05 |
Questions and answers with your speaker
|
| 12:15 |
Interactive discussion: Navigating how you would create a dedicated IO toxicity clinic
|
| 12:30 |
Feedback from interactive discussion: Navigating how you would create a dedicated IO toxicity clinic
|
| 12:40 |
Networking lunch and opportunity to meet the sponsors
|
| Enhancing triaging processes | |
| 1:40 |
Progressing your Immuno-Oncology assessment skills to enhance your clinical practice
Ali Hodge, Nurse Consultant Immunotherapy, University Hospitals Sussex NHS Foundation Trust
|
| 2:05 |
Questions and answers with the speakers
|
| 2:15 |
Interactive discussion: Solidifying your assessment and management of IO toxicities
|
| 2:30 |
Feedback from interactive discussion: Solidifying your assessment and management of IO toxicities
|
| 2:40 |
Networking break and final opportunity meet the sponsors
|
| Establishing urgent pathways | |
| 3:00 |
Managing IO toxicities through an ambulatory pathway
Rachel Bryce, Acute Oncology Service Lead and Nicola Jones, Immunotherapy Service Lead, University Hospitals Plymouth NHS Trust
|
| 3:25 |
Questions and answers with your speakers
|
| 3:35 |
Interactive discussion: Implementing effective processes to cement your urgent Immuno-Oncology pathways
|
| 1:50 |
Feedback from interactive discussion: Implementing effective processes to cement your urgent Immuno-Oncology pathways
|
| 4:00 |
Chairs closing remarks
|
| 4:10 |
Close of Day
|
With thanks to the presenters...
Dr Anna Olsson-Brown
Consultant in Medical Oncology and Clinical Director for Clinical Cancer Care
University Hospitals Sussex NHS Foundation Trust
Trudy Guinan
Immuno-Oncology Nurse Consultant
Clatterbridge Cancer Centre NHS Foundation Trust
Emily Keen
Macmillan Lead Nurse for Immunotherapy
Royal Free London NHS Foundation Trust
Ali Hodge
Nurse Consultant Immunotherapy
University Hospitals Sussex
Rachel Bryce
Acute Oncology Service Lead
University Hospitals Plymouth NHS Trust
Nicola Jones
Immunotherapy Service Lead
University Hospitals Plymouth NHS Trust
James Winterman
Country Manager – UK/IE (Oncology)
Regeneron
With thanks to our conference supporter...
The Immuno-Oncology Clinical Network was established in 2022 by Dr Anna Olsson-Brown and a team of trustees with a passion for improving the care of cancer patients receiving immunotherapy treatment. Dr Olsson-Brown recognised the need to build a multi-disciplinary and multi-specialty community to support healthcare professionals manage the complexities of Immuno-oncology treatments including the auto-immune side effects. The Immuno-Oncology Clinical Network applied for charitable status in Spring 2023.
Who came?
This face-to-face conference was ideal for NHS professionals working in Immunotherapy MDTs. This includes but was not limited to:
- Lead Nurses, CNS, Matrons and Sisters in Cancer, Acute Oncology, Immunotherapy, Chemotherapy, CUP, Rapid Diagnostics and Haematology
- Clinical Nurse Specialists and Consultants in Pain Management and Palliative Care
- Consultant Clinical Oncologists, Consultant Medical Oncologists and Speciality Doctors
- Pharmacists, Medical Managers and Service Managers
Past attendee feedback
This conference was created in collaboration with the IOCN in response to requests made at ‘Managing Immuno-Oncology (IO) Adverse Effects’, the hugely successful return to in-person Immuno-Oncology education which took place in Manchester in February 2024. Take a look at how attendees described that conference:
With thanks to our conference sponsors...
Regeneron is a leading biotechnology company dedicated to inventing life-transforming medicines to help people with serious diseases. Our science-driven approach includes research in eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases and rare diseases.
At MSD, known as Merck & Co., Inc., Kenilworth,
NJ, USA in the United States and Canada, we are unified around our purpose: We
use the power of leading-edge science to save and improve lives around the
world. For more than a century, we’ve been at the forefront of research,
bringing forward medicines, vaccines and innovative health solutions for the
world’s most challenging diseases.
Why sponsor?
Our role at SBK Healthcare is to bring industry together with healthcare professionals so that you can educate and inform your audience. These trail-blazing oncology forums offering dedicated presentation, Q&A, networking and discussion time, each sponsor will be fully immersed into the event and able to effectively engage with your NHS audience.
Interested in having your own event, managed by us?
SBK Healthcare also provides in-house forums. Working closely with you as the client we can research, produce, market and deliver the conference or online forum that best suits the audience and meets your goals.
Reach out today
If you would like more information on our sponsorship options an in-house forum or if you wish to discuss your needs and what solutions may be appropriate for your business, please contact:
Vanessa Pearce
Contact: 01732 897788
Please login to access documentation associated with the event. This is an exclusive benefit for all of the attendees and includes additional and updated documentation.